Here are 11 key notes on orthopedic and spine device companies over the past week.
Alphatec CFO Michael O'Neill resigned, and the company cut its workforce by about 20 percent.
Stryker's spine division unveiled its LITe BIO Delivery System.
An HSS Inspector report found Medicare spent nearly $1.5 billion on seven types of defective heart devices.
Xtant Medical named Carl O'Connell its new president.
The FDA cleared K2M's CASCADIA Lateral Interbody System line expansion.
ChoiceSpine hired Christy Cote as vice president of biologics.
NuVasive appointed Joan Stafslien executive vice president, general counsel.
The global neuromodulation market, led by Medtronic and Boston Scientific, is anticipated to hit more than $5 billion by 2020.
The San Diego-based medical device company Nasseo was awarded a Small Business Innovation Research Grant from the National Science Foundation.
Capital Regional Orthopaedic Associates performed New York state's first meniscus replacement using the investigational NUsurface Meniscus Implant, developed by the biotechnology company Active Implants.
Nativis, a clinical-stage bio-electronics company, named orthopedic surgeon Charles Cobbs, MD, chairman of the scientific and medical advisory board.